+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug & Gene Delivery Devices Market by Technology (Hydrogel Based, Liposomal, Nanoparticle), Device Type (Auto Injector, Infusion Pump, Needle Free Injector), Molecule Type, End User, Application, Therapeutic Area - Global Forecast 2025-2030- Product Image
Drug & Gene Delivery Devices Market by Technology (Hydrogel Based, Liposomal, Nanoparticle), Device Type (Auto Injector, Infusion Pump, Needle Free Injector), Molecule Type, End User, Application, Therapeutic Area - Global Forecast 2025-2030- Product Image
Sale

Drug & Gene Delivery Devices Market by Technology (Hydrogel Based, Liposomal, Nanoparticle), Device Type (Auto Injector, Infusion Pump, Needle Free Injector), Molecule Type, End User, Application, Therapeutic Area - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5336343
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The drug and gene delivery devices market is undergoing rapid transformation, shaped by advances in device engineering, digital integration, and regulatory frameworks. Senior executives navigating this landscape face new opportunities and challenges as innovative delivery platforms and changing trade policies redefine the competitive dynamics for pharmaceutical and medical device organizations.

Market Snapshot: Drug & Gene Delivery Devices

The Drug & Gene Delivery Devices Market grew from USD 4.79 billion in 2024 to USD 5.32 billion in 2025. It is expected to continue growing at a CAGR of 10.75%, reaching USD 8.84 billion by 2030. This expansion is underpinned by breakthrough innovations in drug and gene delivery mechanisms, supportive regulatory policies, and increased adoption of precision therapeutics across key global regions. Accelerated by rising demand for minimally invasive solutions and the integration of digital technologies, the competitive landscape is evolving as manufacturers pursue end-to-end connectivity, improved adherence, and enhanced patient outcomes.

Scope & Segmentation of the Market

  • Technologies Used: Hydrogel-based constructs, liposomal carriers, nanoparticle-enabled formulations, and polymer-based sustained-release platforms are advancing targeted and controlled drug and gene delivery.
  • Device Types: The landscape consists of auto injectors, infusion pumps, needle-free injectors, pen injectors, and syringes supporting diverse administration modalities.
  • Molecule Types: Advances support biologic therapies (monoclonal antibodies, peptides, recombinant proteins), small molecule drugs, and gene therapy vectors (both non-viral lipid/polymer and viral platforms such as adenoviral, lentiviral, and retroviral).
  • End User Segments: Key stakeholders include clinics, home healthcare providers, hospitals, and research laboratories, each demanding tailored delivery solutions for their specific operational settings.
  • Applications: Major applications include controlled release dosing, smart delivery devices, sustained release implants, and targeted delivery approaches focusing on tissue specificity and therapeutic efficacy.
  • Therapeutic Areas: Delivery technologies are enabling innovation within cardiovascular care, diabetes, infectious diseases, and oncology management.
  • Geographies: The report covers the Americas (with focus on the United States, Canada, Mexico, Brazil, and Argentina), Europe, Middle East & Africa (including key markets in the UK, Germany, UAE, Saudi Arabia, and others), and Asia-Pacific (notably China, India, Japan, South Korea, and Southeast Asia).
  • Company Profiles: In-depth analysis is offered for stakeholders such as Becton Dickinson and Company, West Pharmaceutical Services, Terumo Corporation, Gerresheimer AG, Baxter International, Nipro Corporation, Stevanato Group, SHL Medical AG, Ypsomed, and Lonza Group.

Key Takeaways for Senior Decision-Makers

  • Technological convergence is driving seamless integration of digital health and device design, resulting in real-time adherence monitoring and new care delivery pathways.
  • Innovation is shifting rapidly toward modular architectures and materials interoperability, enabling flexible adaptation to therapeutic pipelines and personalized regimens.
  • Partnerships across device OEMs, biopharma firms, and digital health companies are creating comprehensive solutions, streamlining development, and improving patient engagement.
  • Supply chain diversification and proactive risk modeling are critical strategies in light of evolving regulatory landscapes and trade disruptions.
  • Regional demand is heavily influenced by local healthcare infrastructure maturity, reimbursement policies, and government incentives, impacting innovation deployment timelines.

Tariff Impact: Responding to the 2025 U.S. Tariff Adjustments

The introduction of escalated tariffs on key imported materials into the U.S. market is prompting manufacturers to adopt near-shoring initiatives, develop alternative sourcing strategies, and form region-specific alliances. These shifts are driving investment in domestic production capabilities and accelerating the exploration of non-viral vector platforms to sustain innovation without margin compromise. This evolving tariff environment is also encouraging proactive collaboration with local and international partners to navigate cost and supply chain pressures.

Methodology & Data Sources

This report is based on a mixed-methodology approach, including primary interviews with over fifty industry experts and thorough analysis of regulatory filings, company disclosures, and proprietary databases. Insights are validated through thematic and statistical analysis, with all sources peer reviewed by external domain specialists to ensure reliability and transparency.

Why This Report Matters

  • Offers actionable guidance to optimize R&D investments, supplier networks, and market strategies for drug and gene delivery innovation.
  • Enables executives to benchmark their organization’s capabilities against leading competitors and adapt effectively to regional market variations.
  • Supports strategic decisions with segmented analysis and scenario-based recommendations for navigating trade, regulatory, and technological change.

Conclusion

The drug and gene delivery devices market is marked by rapid evolution, necessitating agile strategies and informed investments. Stakeholders who embrace modularity, digital advancement, and supplier diversity will be best positioned to unlock new value amid ongoing industry transformation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of wearable electrochemical sensors for continuous insulin dosing optimization
5.2. Emergence of CRISPR-based lipid nanoparticle formulations for targeted in vivo gene editing
5.3. Integration of AI predictive models in smart infusion pumps for personalized oncology therapies
5.4. Development of ultrasound-triggered microbubble carriers for localized chemotherapeutic delivery
5.5. Advancements in biodegradable polymeric implants for sustained release of peptide therapeutics
5.6. Use of self-amplifying mRNA lipid nanoparticles for enhanced immunotherapy applications
5.7. Regulatory alignment on quality-by-design approaches for scalable gene therapy vector manufacturing
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Drug & Gene Delivery Devices Market, by Technology
8.1. Introduction
8.2. Hydrogel Based
8.3. Liposomal
8.4. Nanoparticle
8.5. Polymer Based
9. Drug & Gene Delivery Devices Market, by Device Type
9.1. Introduction
9.2. Auto Injector
9.3. Infusion Pump
9.4. Needle Free Injector
9.5. Pen Injector
9.6. Syringe
10. Drug & Gene Delivery Devices Market, by Molecule Type
10.1. Introduction
10.2. Biologic
10.2.1. Monoclonal Antibody
10.2.2. Peptide
10.2.3. Recombinant Protein
10.3. Gene Therapy
10.3.1. Non Viral
10.3.1.1. Lipid Based
10.3.1.2. Polymer Based
10.3.2. Viral Vector
10.3.2.1. Adenoviral
10.3.2.2. Lentiviral
10.3.2.3. Retroviral
10.4. Small Molecule
11. Drug & Gene Delivery Devices Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Healthcare
11.4. Hospitals
11.5. Research Laboratories
12. Drug & Gene Delivery Devices Market, by Application
12.1. Introduction
12.2. Controlled Release
12.3. Smart Delivery
12.4. Sustained Release
12.5. Targeted Delivery
13. Drug & Gene Delivery Devices Market, by Therapeutic Area
13.1. Introduction
13.2. Cardiovascular
13.3. Diabetes
13.4. Infectious Diseases
13.5. Oncology
14. Americas Drug & Gene Delivery Devices Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Drug & Gene Delivery Devices Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Drug & Gene Delivery Devices Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Becton Dickinson and Company
17.3.2. West Pharmaceutical Services, Inc.
17.3.3. Terumo Corporation
17.3.4. Gerresheimer AG
17.3.5. Baxter International Inc.
17.3.6. Nipro Corporation
17.3.7. Stevanato Group S.p.A.
17.3.8. SHL Medical AG
17.3.9. Ypsomed Holding AG
17.3.10. Lonza Group AG
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DRUG & GENE DELIVERY DEVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. DRUG & GENE DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. DRUG & GENE DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. DRUG & GENE DELIVERY DEVICES MARKET: RESEARCHAI
FIGURE 28. DRUG & GENE DELIVERY DEVICES MARKET: RESEARCHSTATISTICS
FIGURE 29. DRUG & GENE DELIVERY DEVICES MARKET: RESEARCHCONTACTS
FIGURE 30. DRUG & GENE DELIVERY DEVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DRUG & GENE DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY HYDROGEL BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY HYDROGEL BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY LIPOSOMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY LIPOSOMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NANOPARTICLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NANOPARTICLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY POLYMER BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY POLYMER BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY AUTO INJECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY AUTO INJECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMP, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMP, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NEEDLE FREE INJECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NEEDLE FREE INJECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PEN INJECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PEN INJECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PEPTIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PEPTIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY LIPID BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY LIPID BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY POLYMER BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY POLYMER BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ADENOVIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ADENOVIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY LENTIVIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY LENTIVIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY RETROVIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY RETROVIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SMART DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SMART DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 141. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 142. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 143. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 144. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 145. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 146. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 147. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 148. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 149. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 150. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 151. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2024 (USD MILLION)
TABLE 152. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2025-2030 (USD MILLION)
TABLE 153. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 154. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 155. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 160. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 161. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 162. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 163. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 164. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 165. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 166. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 167. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 168. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 169. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 170. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 171. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2024 (USD MILLION)
TABLE 172. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2025-2030 (USD MILLION)
TABLE 173. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 174. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 175. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 180. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 263. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 264. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 265. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 266. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 267. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 268. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 269. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 270. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 271. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 272. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 273. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2024 (USD MILLION)
TABLE 274. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2025-2030 (USD MILLION)
TABLE 275. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 276. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 277. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 282. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 283. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 284. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 285. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 286. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 287. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 288. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 289. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 290. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 291. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 292. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 293. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2024 (USD MILLION)
TABLE 294. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2025-2030 (USD MILLION)
TABLE 295. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 296. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 297. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 302. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA DRUG & GENE DELIV

Samples

Loading
LOADING...

Companies Mentioned

  • Becton Dickinson and Company
  • West Pharmaceutical Services, Inc.
  • Terumo Corporation
  • Gerresheimer AG
  • Baxter International Inc.
  • Nipro Corporation
  • Stevanato Group S.p.A.
  • SHL Medical AG
  • Ypsomed Holding AG
  • Lonza Group AG

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.32 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.84 Billion
Compound Annual Growth Rate10.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Drug and Gene Delivery Devices Market Report and Forecast 2025-2034 - Product Image

Drug and Gene Delivery Devices Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Drug and Gene Delivery Devices - Global Strategic Business Report - Product Image

Drug and Gene Delivery Devices - Global Strategic Business Report

  • Report
  • 278 Pages
  • Global
From
Drug and Gene Delivery Devices Market Report 2025 - Product Image

Drug and Gene Delivery Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Gene Delivery Technologies Market by Delivery Vector Type (Non-Viral Vector, Viral Vector), Therapeutic Application (Cardiovascular Therapies, Genetic Disorders, Oncology), Product, End User, Technology - Global Forecast 2025-2030 - Product Image

Gene Delivery Technologies Market by Delivery Vector Type (Non-Viral Vector, Viral Vector), Therapeutic Application (Cardiovascular Therapies, Genetic Disorders, Oncology), Product, End User, Technology - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Gene Therapy Market, 6th Edition: Industry Trends and Global Forecasts to 2035 - Therapeutic Area, Type of Vector, Type of Therapy, Type of Gene Delivery Method, Route of Administration, Geographical Region, Leading Market Players and Sales Forecast - Product Image

Gene Therapy Market, 6th Edition: Industry Trends and Global Forecasts to 2035 - Therapeutic Area, Type of Vector, Type of Therapy, Type of Gene Delivery Method, Route of Administration, Geographical Region, Leading Market Players and Sales Forecast

  • Report
  • 972 Pages
  • Global
From

About the Drug and Gene Delivery Market

The Drug and Gene Delivery market within the context of Genomics is a rapidly growing field of research and development. It involves the use of various technologies to deliver drugs and genes to specific cells or tissues in the body. This can be done through a variety of methods, such as viral vectors, liposomes, nanoparticles, and other delivery systems. These technologies are used to treat a variety of diseases, including cancer, cardiovascular diseases, and neurological disorders. The Drug and Gene Delivery market is driven by the increasing demand for personalized medicine, as well as the need for more effective treatments for diseases. Additionally, advances in gene editing technologies have enabled the development of more precise and targeted therapies. Some of the major players in the Drug and Gene Delivery market include Novartis, Merck, Pfizer, Sanofi, and AstraZeneca. Other companies in the market include Amgen, GlaxoSmithKline, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.